Blanket purchase agreement for xyrem

Ended Awarded Last action

Contract number
36E79719A0030
Awardee
Awarding agency
Task orders
4 $360,506 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$796,184 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$150,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a Blanket Purchase Agreement (BPA) to Jazz Pharmaceuticals, Inc. for the delivery of specialty pharmaceutical products, primarily the sleep disorder medication Xyrem. The $150 million BPA is issued under Jazz Pharmaceuticals' Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract, allowing the VA to efficiently procure needed medications for its healthcare facilities. Four task orders worth up to $717,519 have been issued to date by the VA's Veterans Integrated Service Networks to supply Xyrem to VA medical centers in Maine and California. The contracts support the VA's mission to provide pharmaceutical products to veterans through its nationwide healthcare system. As the prime contractor, Jazz Pharmaceuticals has also been awarded multiple firm fixed price call orders under the BPA and FSS contract to deliver Xyrem and related sleep disorder treatments to VA facilities in California and other regions. No set-aside designations were used for these awards.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00018 · This modification is issued to update ordering forms for xyrem and xywav on BPA 36E79719A0030. $0
Other Administrative Action P00017 · Update ordering forms $0
Supplemental Agreement for work within scope P00016 · Temporary price reductions $0
Supplemental Agreement for work within scope P00015 · 2024 public law pricing updates $0
Exercise an Option P00014 · Exercise option year 4 - BPA 36E79719A0030 $0
Supplemental Agreement for work within scope P00013 · Temporary price reduction $0
Supplemental Agreement for work within scope P00012 · 2023 public law pricing updates $0
Exercise an Option P00011 · Exercise option year 3 on BPA 36E79719A0030 $0
Supplemental Agreement for work within scope P00010 · Updated prescription ordering forms $0
Supplemental Agreement for work within scope P00009 · Xywav temporary price reduction $0
Supplemental Agreement for work within scope P00008 · Updated ordering forms $0
Supplemental Agreement for work within scope P00007 · 2022 PL updates $0
Exercise an Option P00006 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00005 · Voluntary temporary price reduction (TPR) for xywav $0
Supplemental Agreement for work within scope P00004 · 2021 public law pricing updates $0
Supplemental Agreement for work within scope P00003 · Product add (xywav) and incorporate revised ordering documents (xyrem) $0
Exercise an Option P00002 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00001 · 2020 public law pricing update. $0
Original award $0
Show all 19

Quick answers

Who was awarded contract 36E79719A0030?

36E79719A0030 was awarded to Jazz Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on August 15, 2019.

How much is contract 36E79719A0030 worth?

Orders under 36E79719A0030 have obligated $360,506. Their combined current value, with exercised options, is $796,184. 36E79719A0030's own ceiling is $150,000,000.

How many orders have been placed under contract 36E79719A0030?

4 orders have been placed under 36E79719A0030, the latest on October 1, 2019.

Who can order from contract 36E79719A0030?

36E79719A0030 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79719A0030 under another contract?

Yes. 36E79719A0030 is a blanket purchase agreement under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79719A0030 competed?

The extent of competition for 36E79719A0030 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV